Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 3/1998

01-06-1998

Keratinocyte Growth Factor Decreases Pulmonary Edema, Transforming Growth Factor-Beta and Platelet-Derived Growth Factor-BB Expression, and Alveolar Type II Cell Loss in Bleomycin-Induced Lung Injury

Authors: Eunhee S. Yi, Moses Salgado, Scott Williams, Seong-Jin Kim, Eliezer Masliah, Songmei Yin, Thomas R. Ulich

Published in: Inflammation | Issue 3/1998

Login to get access
Metadata
Title
Keratinocyte Growth Factor Decreases Pulmonary Edema, Transforming Growth Factor-Beta and Platelet-Derived Growth Factor-BB Expression, and Alveolar Type II Cell Loss in Bleomycin-Induced Lung Injury
Authors
Eunhee S. Yi
Moses Salgado
Scott Williams
Seong-Jin Kim
Eliezer Masliah
Songmei Yin
Thomas R. Ulich
Publication date
01-06-1998
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Inflammation / Issue 3/1998
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1023/A:1022304317111

Other articles of this Issue 3/1998

Inflammation 3/1998 Go to the issue

OriginalPaper

Activation of Transcription Factors and IL-8 Expression in Neutrophils Stimulated with Lipopolysaccharide from Porphyromonas gingivalis

OriginalPaper

Enhancement of the Effect of Methotrexate on Collagen II Induced Arthritis in Mice by Nicotinamide

OriginalPaper

In Vivo Recruitment of Neutrophils: Consistent Requirements for L-Arginine and Variable Requirements for Complement and Adhesion Molecules

OriginalPaper

Arachidonic Acid (AA) and Tetradecanoylphorbol Acetate (TPA) Exert Systemic Effects When Applied Topically in the Mouse

OriginalPaper

Oxidation of the Mesangial Matrix Metalloproteinase-2 Impairs Gelatinolytic Activity

OriginalPaper

Effects of Chronic Treatment with Indomethacin at Clinically Relevant Doses on Intestinal Tissue 6-Keto Prostaglandin F1α and Leukotriene B4 Level in Relation to Gastroenteropathy

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits